litlas
ログインアカウント作成

Michael P. Whyte

1969–2024 年に発表

122
論文数
23,004
被引用数
88
h 指数
120
i10 指数

被引用数

Michael P. Whyte の年別被引用数1971 年: 被引用 1 件1976 年: 被引用 1 件1977 年: 被引用 1 件1980 年: 被引用 2 件1981 年: 被引用 3 件1982 年: 被引用 4 件1983 年: 被引用 1 件1984 年: 被引用 14 件1985 年: 被引用 8 件1986 年: 被引用 8 件1987 年: 被引用 8 件1988 年: 被引用 14 件1989 年: 被引用 18 件1990 年: 被引用 19 件1991 年: 被引用 29 件1992 年: 被引用 37 件1993 年: 被引用 9 件1994 年: 被引用 27 件1995 年: 被引用 36 件1996 年: 被引用 21 件1997 年: 被引用 41 件1998 年: 被引用 45 件1999 年: 被引用 53 件2000 年: 被引用 67 件2001 年: 被引用 56 件2002 年: 被引用 73 件2003 年: 被引用 103 件2004 年: 被引用 108 件2005 年: 被引用 113 件2006 年: 被引用 115 件2007 年: 被引用 180 件2008 年: 被引用 125 件2009 年: 被引用 124 件2010 年: 被引用 157 件2011 年: 被引用 143 件2012 年: 被引用 199 件2013 年: 被引用 193 件2014 年: 被引用 152 件2015 年: 被引用 187 件2016 年: 被引用 216 件2017 年: 被引用 249 件2018 年: 被引用 134 件2019 年: 被引用 524 件2020 年: 被引用 689 件2021 年: 被引用 500 件2022 年: 被引用 365 件2023 年: 被引用 227 件2024 年: 被引用 376 件2025 年: 被引用 213 件2026 年: 被引用 3 件1972〜1975 年は被引用が無いため表示していません1978〜1979 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,688 件、この内訳の 28.4%イギリス: 引用元論文 621 件、この内訳の 10.4%カナダ: 引用元論文 329 件、この内訳の 5.5%ドイツ: 引用元論文 314 件、この内訳の 5.3%イタリア: 引用元論文 277 件、この内訳の 4.7%フランス: 引用元論文 271 件、この内訳の 4.6%日本: 引用元論文 235 件、この内訳の 3.9%中国: 引用元論文 232 件、この内訳の 3.9%オーストラリア: 引用元論文 197 件、この内訳の 3.3%オランダ: 引用元論文 161 件、この内訳の 2.7%スペイン: 引用元論文 154 件、この内訳の 2.6%ベルギー: 引用元論文 129 件、この内訳の 2.2%
0%28.4%その他 22.5%

機関

分野

  • Medicine61.9%
  • Biochemistry, Genetics and Molecular Biology32%
  • Neuroscience1.6%
  • Engineering1%
  • Nursing0.9%
  • Immunology and Microbiology0.7%
  • その他1.9%

トピック

  • Bone health and treatments7.3%
  • Bone health and osteoporosis research6.3%
  • Parathyroid Disorders and Treatments5.3%
  • Alkaline Phosphatase Research Studies4.5%
  • Bone Metabolism and Diseases4.3%
  • Bone and Joint Diseases2.7%
  • その他69.6%

共著者

全論文

検索で開く
  1. Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research

    著者: Elizabeth Shane, David B. Burr, Bo Abrahamsen, Robert A. Adler, Thomas D. Brown, Angela M. Cheung, Felicia Cosman, Jeffrey R. Curtis, Richard Dell, David W. Dempster, Peter R. Ebeling, Thomas A. Einhorn, Harry K. Genant, Piet Geusens, Klaus Klaushofer, Joseph M. Lane, Fergus McKiernan, Ross E. McKinney, Alvin Choong Meng Ng, Jeri W. Nieves, Regis J. O’Keefe, Socrates E. Papapoulos, Tet Sen Howe, Marjolein C. H. van der Meulen, Robert S. Weinstein, Michael P. Whyte - Journal of Bone and Mineral Research 2013 被引用: 2,118

  2. Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial

    著者: Erik A. Imel, Francis H. Glorieux, Michael P. Whyte, Craig F. Munns, Leanne M. Ward, Ola Nilsson, Jill H. Simmons, Raja Padidela, Noriyuki Namba, Hae Il Cheong, Pisit Pitukcheewanont, Etienne Sochett, Wolfgang Högler, Koji Muroya, Hiroyuki Tanaka, Gary S. Gottesman, Andrew Biggin, Farzana Perwad, Meng Mao, Chao-Yin Chen, Alison Skrinar, Javier San Martín, Anthony A. Portale - The Lancet 2019 被引用: 367

  3. Burosumab Therapy in Children with X-Linked Hypophosphatemia

    著者: Thomas O. Carpenter, Michael P. Whyte, Erik A. Imel, Annemieke M. Boot, Wolfgang Högler, Agnès Linglart, Raja Padidela, William van’t Hoff, Meng Mao, Chao-Yin Chen, Alison Skrinar, Emil Kakkis, Javier San Martín, Anthony A. Portale - New England Journal of Medicine 2018 被引用: 473

  4. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein

    著者: Giles D. Watts, Jill Wymer, Margaret J. Kovach, Sarju Mehta, Steven Mumm, Daniel Darvish, Alan Pestronk, Michael P. Whyte, Virginia Kimonis - Nature Genetics 2004 被引用: 1,398

  5. Hypophosphatasia — aetiology, nosology, pathogenesis, diagnosis and treatment

    著者: Michael P. Whyte - Nature Reviews Endocrinology 2016 被引用: 500

  6. Factors influencing success of clinical genome sequencing across a broad spectrum of disorders

    著者: Jenny C. Taylor, Hilary C. Martin, Stefano Lise, John Broxholme, Jean‐Baptiste Cazier, Andy Rimmer, Alexander Kanapin, Gerton Lunter, Simon Fiddy, Chris Allan, A.R. Aricescu, Moustafa Attar, Christian Babbs, Jennifer Becq, David Beeson, Celeste Bento, P Bignell, Edward Blair, Veronica J. Buckle, Katherine R. Bull, Ondřej Cais, Holger Cario, Helen Chapel, Richard R. Copley, Richard J. Cornall, Jude Craft, Karin Dahan, Emma E. Davenport, Calliope A. Dendrou, Olivier Devuyst, Aimée L Fenwick, Jonathan Flint, Lars Fugger, Rodney D. Gilbert, Anne Goriely, Angie Green, Ingo H. Greger, Russell Grocock, Anja V. Gruszczyk, Robert Hastings, Edouard Hatton, Douglas R. Higgs, Adrian V. S. Hill, Chris Holmes, Malcolm F. Howard, Linda Hughes, Peter Humburg, David H. Johnson, Fredrik Karpe, Zoya Kingsbury, Usha Kini, Julian C. Knight, Jonathan Krohn, Sarah Lamble, Craig B. Langman, Lorne Lonie, Joshua Luck, Davis J. McCarthy, Simon J. McGowan, Mary Frances McMullin, Kerry A. Miller, Lisa Murray, Andrea H. Németh, M. Andrew Nesbit, David Nutt, Elizabeth Ormondroyd, Annette Oturai, Alistair T. Pagnamenta, Smita Y. Patel, Melanie J. Percy, Nayia Petousi, Paolo Piazza, Siân E. Piret, Guadalupe Polanco‐Echeverry, Niko Popitsch, Fiona Powrie, Christopher W. Pugh, Lynn Quek, Peter A. Robbins, Kathryn Robson, Alexandra Russo, Natasha Sahgal, Pauline A. van Schouwenburg, Anna Schuh, Earl D. Silverman, Alison Simmons, Per Soelberg Sørensen, Elizabeth Sweeney, John Taylor, Rajesh V. Thakker, Ian Tomlinson, Amy Trebes, Stephen R.F. Twigg, Holm H. Uhlig, Paresh Vyas, Tim J. Vyse, Steven A. Wall, Hugh Watkins, Michael P. Whyte, Lorna Witty ほか 10 名 - Nature Genetics 2015 被引用: 388

  7. Efficacy and safety of burosumab in children aged 1–4 years with X-linked hypophosphataemia: a multicentre, open-label, phase 2 trial

    著者: Michael P. Whyte, Thomas O. Carpenter, Gary S. Gottesman, Meng Mao, Alison Skrinar, Javier San Martín, Erik A. Imel - The Lancet Diabetes & Endocrinology 2019 被引用: 182

  8. Sustained Efficacy and Safety of Burosumab, a Monoclonal Antibody to FGF23, in Children With X-Linked Hypophosphatemia

    著者: Agnès Linglart, Erik A. Imel, Michael P. Whyte, Anthony A. Portale, Wolfgang Högler, Annemieke M. Boot, Raja Padidela, William van’t Hoff, Gary S. Gottesman, Angel Chen, Alison Skrinar, Mary Scott Roberts, Thomas O. Carpenter - The Journal of Clinical Endocrinology & Metabolism 2021 被引用: 89

  9. Alkaline Phosphatase and Hypophosphatasia

    著者: José Luís Millán, Michael P. Whyte - Calcified Tissue International 2015 被引用: 393

  10. Enzyme-Replacement Therapy in Life-Threatening Hypophosphatasia

    著者: Michael P. Whyte, Cheryl R. Greenberg, Nada Salman, Michael B. Bober, William H. McAlister, Deborah Wenkert, Bradley J. Van Sickle, Jill H. Simmons, Terence S. Edgar, Martin Bauer, Mohamed A. Hamdan, Nick Bishop, Richard E. Lutz, Mairead McGinn, Stanley Craig, Jean N. Moore, John W. Taylor, Robert Cleveland, William R. Cranley, Ruth Lim, Tom D. Thacher, J. Mayhew, Matthew Downs, José Luís Millán, Alison Skrinar, Philippe Crine, Hal Landy - New England Journal of Medicine 2012 被引用: 566

  11. Hypophosphatasia: An overview For 2017

    著者: Michael P. Whyte - Bone 2017 被引用: 240

  12. Effect of Burosumab Compared With Conventional Therapy on Younger vs Older Children With X-linked Hypophosphatemia

    著者: Leanne M. Ward, Francis H. Glorieux, Michael P. Whyte, Craig F. Munns, Anthony A. Portale, Wolfgang Högler, Jill H. Simmons, Gary S. Gottesman, Raja Padidela, Noriyuki Namba, Hae Il Cheong, Ola Nilsson, Meng Mao, Angel Chen, Alison Skrinar, Mary Scott Roberts, Erik A. Imel - The Journal of Clinical Endocrinology & Metabolism 2022 被引用: 76

  13. Hypophosphatasia: Validation and expansion of the clinical nosology for children from 25years experience with 173 pediatric patients

    著者: Michael P. Whyte, Fan Zhang, Deborah Wenkert, William H. McAlister, Karen Mack, Marci C. Benigno, Stephen P. Coburn, Susan Wagy, Donna M. Griffin, Karen L. Ericson, Steven Mumm - Bone 2015 被引用: 262

  14. Asfotase Alfa Treatment Improves Survival for Perinatal and Infantile Hypophosphatasia

    著者: Michael P. Whyte, Cheryl R. Greenberg, Keiichi Ozono, Richard J. Riese, Scott Moseley, Agustin Melian, David D. Thompson, Nicholas Bishop, Christine Hofmann - The Journal of Clinical Endocrinology & Metabolism 2015 被引用: 265

  15. Alkaline Phosphatase: Discovery and Naming of Our Favorite Enzyme

    著者: Alejandro F. Siller, Michael P. Whyte - Journal of Bone and Mineral Research 2017 被引用: 130

  16. Skeletal and extraskeletal disorders of biomineralization

    著者: Michael T. Collins, Gemma Marcucci, Hans‐Joachim Anders, Giovanni Beltrami, Jane A. Cauley, Peter R. Ebeling, Rajiv Kumar, Agnès Linglart, Luca Sangiorgi, Dwight A. Towler, Ria Weston, Michael P. Whyte, Maria Luisa Brandi, B.L. Clarke, Rajesh V. Thakker - Nature Reviews Endocrinology 2022 被引用: 66

  17. Pharmacodynamics of asfotase alfa in adults with pediatric-onset hypophosphatasia

    著者: Lothar Seefried, Priya S. Kishnani, Scott Moseley, Andrew Denker, Eric Watsky, Michael P. Whyte, Kathryn Dahir - Bone 2020 被引用: 39

  18. Alkaline Phosphatase Knock-Out Mice Recapitulate the Metabolic and Skeletal Defects of Infantile Hypophosphatasia

    著者: K N Fedde, Libby A. Blair, Julie Silverstein, Stephen P. Coburn, Lawrence M. Ryan, Robert S. Weinstein, Katrina G. Waymire, Sonoko Narisawa, José Luís Millán, Grant R. MacGregor, Michael P. Whyte - Journal of Bone and Mineral Research 1999 被引用: 400

  19. Enzyme Replacement Therapy for Murine Hypophosphatasia

    著者: José Luís Millán, Sonoko Narisawa, Isabelle Lemire, Thomas P. Loisel, Guy Boileau, Pierre Léonard, Svetlana Gramatikova, Robert Terkeltaub, Nancy P. Camacho, Marc D. McKee, Philippe Crine, Michael P. Whyte - Journal of Bone and Mineral Research 2007 被引用: 259

  20. Asfotase alfa therapy for children with hypophosphatasia

    著者: Michael P. Whyte, Katherine L. Madson, Dawn Phillips, Amy Reeves, William H. McAlister, Amy Yakimoski, Karen Mack, Kim Hamilton, K. G. Kagan, Kenji P. Fujita, David D. Thompson, Scott Moseley, Tatjana Odrljin, Cheryl R. Greenberg - JCI Insight 2016 被引用: 172

  21. Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial

    著者: Michael P. Whyte, Jill H. Simmons, Scott Moseley, Kenji P. Fujita, Nicholas Bishop, Nada Salman, John W. Taylor, Dawn Phillips, Mairead McGinn, William H. McAlister - The Lancet Diabetes & Endocrinology 2018 被引用: 145

  22. Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia

    著者: Priya S. Kishnani, Cheryl R. Greenberg, Frank Rauch, M. Tariq Bhatti, Scott Moseley, Andrew Denker, Eric Watsky, Michael P. Whyte - Bone 2018 被引用: 144

  23. AP2σ Mutations Impair Calcium-Sensing Receptor Trafficking and Signaling, and Show an Endosomal Pathway to Spatially Direct G-Protein Selectivity

    著者: Caroline M. Gorvin, Angela Rogers, Benoît Hastoy, Andrei I. Tarasov, Morten Frost, Silvia Sposini, Asuka Inoue, Michael P. Whyte, Patrik Rorsman, Aylin C. Hanyaloglu, Gerda E. Breitwieser, Rajesh V. Thakker - Cell Reports 2018 被引用: 91

  24. Patient-Reported Outcomes from a Randomized, Active-Controlled, Open-Label, Phase 3 Trial of Burosumab Versus Conventional Therapy in Children with X-Linked Hypophosphatemia

    著者: Raja Padidela, Michael P. Whyte, Francis H. Glorieux, Craig F. Munns, Leanne M. Ward, Ola Nilsson, Anthony A. Portale, Jill H. Simmons, Noriyuki Namba, Hae Il Cheong, Pisit Pitukcheewanont, Etienne Sochett, Wolfgang Högler, Koji Muroya, Hiroyuki Tanaka, Gary S. Gottesman, Andrew Biggin, Farzana Perwad, Angela Williams, Annabel Nixon, Wei Sun, Angel Chen, Alison Skrinar, Erik A. Imel - Calcified Tissue International 2021 被引用: 48